IDS Trading Update September 2009
Immunodiagnostic Systems Holdings plc (“IDS” or “the Company”), a leading producer of diagnostic testing kits for the clinical and research markets, announces a trading update for the six month period to 30 September 2009, prior to the release of its half-yearly report on Monday, 30 November 2009.
Turnover from continuing operations for the period is 56% ahead of the comparative period for last year at £16.9 million (2008: £10.8 million) and 20% ahead of 2008 H2 on a like for like basis. Revenues have increased in all direct sales territories with substantial growth in the USA, France and Germany. Sales of our Vitamin D products continue to grow at an impressive rate, having doubled compared to same period last year.